Bulletin
Investor Alert

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Dec 7, 2021, 7:59 p.m.

/zigman2/quotes/209129655/composite

$

9.45

Change

+0.0099 +0.10%

Volume

Volume 122,901

Quotes are delayed by 20 min

/zigman2/quotes/209129655/composite

Today's close

$ 9.15

$ 9.44

Change

+0.29 +3.17%

Day low

Day high

$9.25

$9.64

Open

52 week low

52 week high

$7.16

$67.00

Open

Company Description

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products...

Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research, cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in New York, NY.

Valuation

Price to Sales Ratio

8.93

Price to Book Ratio

1.70

Enterprise Value to EBITDA

-6,527.28

Enterprise Value to Sales

14.54

Total Debt to Enterprise Value

0.19

Efficiency

Revenue/Employee

244,326.00

Income Per Employee

-174,962.00

Receivables Turnover

7.73

Total Asset Turnover

0.15

Liquidity

Current Ratio

2.20

Quick Ratio

1.56

Cash Ratio

1.22

Profitability

Gross Margin

17.14

Operating Margin

-13.36

Pretax Margin

-67.15

Net Margin

-71.61

Return on Assets

-10.62

Return on Equity

-15.49

Return on Total Capital

-2.23

Return on Invested Capital

-12.05

Capital Structure

Total Debt to Total Equity

21.05

Total Debt to Total Capital

17.39

Total Debt to Total Assets

15.58

Long-Term Debt to Equity

19.94

Long-Term Debt to Total Capital

16.47

Officers and Executives

Name Age Officer Since Title
Mr. Irwin David Simon 62 2021 Chairman & Chief Executive Officer
Mr. James Meiers 62 2021 President-Canada
Mr. Carl A. Merton - 2021 Chief Financial Officer
Mr. Lloyd Brathwaite - 2021 Chief Information Officer
Dr. Joshua Eades - 2014 Chief Science Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/19/2021 Irwin David Simon
President and CEO; Director
120,291   Derivative/Non-derivative trans. at $12.68 per share. 1,525,289
08/19/2021 Irwin David Simon
President and CEO; Director
36,088   Derivative/Non-derivative trans. at $12.68 per share. 457,595
08/19/2021 Irwin David Simon
President and CEO; Director
89,495   Derivative/Non-derivative trans. at $12.68 per share. 1,134,796
08/19/2021 James R. Meiers
Head of Canada
7,299   Derivative/Non-derivative trans. at $12.68 per share. 92,551
08/19/2021 James R. Meiers
Head of Canada
7,633   Derivative/Non-derivative trans. at $12.68 per share. 96,786
08/19/2021 Carl A. Merton
Chief Financial Officer
50,247   Derivative/Non-derivative trans. at $12.68 per share. 637,131
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
8,925   Derivative/Non-derivative trans. at $12.68 per share. 113,169
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
10,505   Derivative/Non-derivative trans. at $12.68 per share. 133,203
08/19/2021 Irwin David Simon
President and CEO; Director
242,277   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
72,683   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Carl A. Merton
Chief Financial Officer
96,628   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,444   Derivative/Non-derivative trans. at $0 per share. 0
08/19/2021 Denise Menikheim Faltischek
Chief Strategy Officer
31,125   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Irwin David Simon
President and CEO; Director
90,126   Derivative/Non-derivative trans. at $14.1 per share. 1,270,776
08/12/2021 James R. Meiers
Head of Canada
7,926   Derivative/Non-derivative trans. at $14.1 per share. 111,756
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
9,163   Derivative/Non-derivative trans. at $14.1 per share. 129,198
08/12/2021 Irwin David Simon
President and CEO; Director
180,251   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 James R. Meiers
Head of Canada
32,548   Derivative/Non-derivative trans. at $0 per share. 0
08/12/2021 Denise Menikheim Faltischek
Chief Strategy Officer
26,443   Derivative/Non-derivative trans. at $0 per share. 0
08/07/2021 Irwin David Simon
President and CEO; Director
12,926   Derivative/Non-derivative trans. at $14.42 per share. 186,392
08/07/2021 Irwin David Simon
President and CEO; Director
25,852   Derivative/Non-derivative trans. at $0 per share. 0
08/05/2021 Brendan Kennedy
Director
300,000   Disposition at $14.46 per share. 4,338,000
08/04/2021 Brendan Kennedy
Director
300,000   Disposition at $14.08 per share. 4,224,000
07/16/2021 Brendan Kennedy
Director
300,000   Disposition at $14.04 per share. 4,212,000
07/15/2021 Brendan Kennedy
Director
76,289   Disposition at $15.18 per share. 1,158,067
07/15/2021 Brendan Kennedy
Director
223,711   Disposition at $14.5 per share. 3,243,809
06/18/2021 Brendan Kennedy
Director
400,000   Disposition at $17.19 per share. 6,876,000
06/17/2021 Brendan Kennedy
Director
400,000   Disposition at $17.97 per share. 7,188,000
06/03/2021 James R. Meiers
Head of Canada
23,826   Disposition at $19.64 per share. 467,942
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. Global X Cannabis ETF hits lowest point since March 2020

    12:39 p.m. Dec. 1, 2021

    - Steve Gelsi

  2. Poseidon launches new cannabis ETF on the NYSE

    10:20 a.m. Nov. 18, 2021

    - Steve Gelsi

  3. Tilray stock price target cut to $11.80 vs. $18.00 at Cantor

    6:34 a.m. Nov. 1, 2021

    - Ciara Linnane

  4. Tilray downgraded to neutral vs. overweight at Cantor Fitzgerald

    6:34 a.m. Nov. 1, 2021

    - Ciara Linnane

  5. MemeMarkets: “The Market of the Apes” with Dave Lauer

    3:19 p.m. Oct. 19, 2021

    - Thornton McEnery

  6. Tilray stock price target cut to $10.00 from $11.50 at Stifel Nicolaus

    7:02 a.m. Oct. 8, 2021

    - Tomi Kilgore

  7. Tilray Stock Rallies Despite a $35 Million Loss

    6:09 p.m. Oct. 7, 2021

    - Karishma Vanjani

  8. Tilray posts larger-than-expected loss

    7:18 a.m. Oct. 7, 2021

    - Steve Gelsi

  9. CORRECTED: Tilray Q1 FactSet consensus loss per share 6 cents; revenue $172.6 mln

    7:16 a.m. Oct. 7, 2021

    - Ciara Linnane

  10. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Why Tilray, Aurora Cannabis, and Canopy Growth Are Glowing Green

    1:32 p.m. Today

    - Motley Fool

  2. 2021 - Cannabis Year In Review

    9:14 a.m. Dec. 5, 2021

    - Seeking Alpha

  3. Cannabis REITs: When They Go Low, We Get High

    10:00 a.m. Dec. 3, 2021

    - Seeking Alpha

  4. Tilray Stock: Bull vs. Bear

    8:56 a.m. Nov. 30, 2021

    - Motley Fool

  5. 3 Things About Sundial Growers That Smart Investors Know

    6:02 a.m. Nov. 30, 2021

    - Motley Fool

  6. Implied Volatility Surging for Tilray (TLRY) Stock Options

    10:41 a.m. Nov. 29, 2021

    - Zacks.com

  7. Top Cannabis Beverage Stocks to Consider Heading into 2022

    9:29 a.m. Nov. 29, 2021

    - Baystreet.ca

  8. High Tide Closes Acquisition of NuLeaf Naturals

    6:00 a.m. Nov. 29, 2021

    - CNW Group

  9. Down 30% in 6 Months: Is Tilray Still a Buy?

    7:55 a.m. Nov. 21, 2021

    - Motley Fool

  10. Is Tilray a Buy?

    6:25 a.m. Nov. 20, 2021

    - Motley Fool

  11. Loading more headlines...

At a Glance

Tilray, Inc.

655 Madison Avenue

19th floor

New York, New York 10065

Phone

1 5193228800

Industry

Farming

Sector

Agriculture

Fiscal Year-end

05/2022

Revenue

$513.09M

Net Income

$-367.42M

2021 Sales Growth

207.3%

Employees

2,100

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Global CBD Market Retail Sales Jump Along With Rising Consumer Acceptance

    10:49 a.m. Dec. 1, 2021

    - Financial News Media

  2. Top Cannabis Beverage Stocks to Consider Heading into 2022

    8:57 a.m. Nov. 29, 2021

    - Baystreet.ca

  3. High Tide Inc. (HITI) Closes Acquisition of NuLeaf Naturals

    7:37 a.m. Nov. 29, 2021

    - Marijuana Stocks

  4. High Tide Closes Acquisition of NuLeaf Naturals

    6:02 a.m. Nov. 29, 2021

    - BusinessWire - BZX

  5. High Tide Closes Acquisition of NuLeaf Naturals

    6:00 a.m. Nov. 29, 2021

    - PR Newswire - PRF

  6. Tilray Hosts 2021 Annual Meeting of Shareholders

    5:15 p.m. Nov. 22, 2021

    - GlobeNewswire

  7. Medical Marijuana Market to Record a Noteworthy CAGR During 2028

    11:59 a.m. Nov. 18, 2021

    - AmericaNewsHour

  8. Tilray to Participate in Two Jefferies Investor Conferences

    7:30 a.m. Nov. 11, 2021

    - GlobeNewswire

  9. Loading more headlines...
Trending Tickers
  • /zigman2/quotes/200172674/composite EDSA+102.72%
  • /zigman2/quotes/209901640/composite SPY-1.67%
  • /zigman2/quotes/201343976/composite UVXY+16.31%
  • /zigman2/quotes/221104327/composite LCID+4.83%
  • /zigman2/quotes/214109287/composite SDC-3.13%
X
Powered by StockTwits
Link to MarketWatch's Slice.